Literature DB >> 1699533

Effect of heparin on the binding affinity of acidic FGF for the cloned human FGF receptors, flg and bek.

J M Kaplow1, F Bellot, G Crumley, C A Dionne, M Jaye.   

Abstract

Heparin potentiates the mitogenic activity of acidic fibroblast growth factor (aFGF) by 20-100 fold but mechanisms detailing this potentiation have not yet been fully elucidated. We report that heparin increases the binding affinity of aFGF for the two cloned and overexpressed human FGF receptors, flg and bek, by 2-3 fold. This increase in binding affinity, together with previous data demonstrating a 3-5 fold increase in the stability of aFGF, are likely to account for a significant portion of heparin's potentiation of aFGF activity observed in biological assay systems.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1699533     DOI: 10.1016/s0006-291x(05)80179-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Acidic and basic fibroblast growth factors down-regulate collagen gene expression in keloid fibroblasts.

Authors:  E M Tan; S Rouda; S S Greenbaum; J H Moore; J W Fox; S Sollberg
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

Review 2.  Role of laminin-nidogen complexes in basement membrane formation during embryonic development.

Authors:  M Dziadek
Journal:  Experientia       Date:  1995-09-29

3.  Expression of the IIIc variant of FGF receptor-1 confers mitogenic responsiveness to heparin and FGF-5 in TAKA-1 pancreatic ductal cells.

Authors:  M Kornmann; M E Lopez; H G Beger; M Korc
Journal:  Int J Pancreatol       Date:  2001

4.  Three-dimensional structure of human basic fibroblast growth factor.

Authors:  A E Eriksson; L S Cousens; L H Weaver; B W Matthews
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

5.  Platelet factor 4 modulates the mitogenic activity of basic fibroblast growth factor.

Authors:  J B Watson; S B Getzler; D F Mosher
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.